BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

TWi Pharmaceuticals, Inc. 

4F, No. 41, Lane 221
Kang Chien Rd.
Nei Hu Dist.  Taipei  114 
Phone: 886-2-26573350 Fax: 886-2-26573391


SEARCH JOBS




Industry
Pharmaceutical

Segment
Pharmaceuticals





 Company News
TWi Pharmaceuticals, Inc. Announced The Promotion Of R&D EVP Jianbo Xie As COO 5/14/2015 6:40:58 AM
TWi Pharmaceuticals, Inc. Announces Settlement With Takeda (TKPYY) On Dexilant(R) Litigation 4/27/2015 7:01:20 AM
TWi Pharmaceuticals, Inc. USA Announces The Receipt Of State Sales Licenses From All 50 States In The U.S. 4/17/2015 7:36:06 AM
TWi Pharmaceuticals, Inc. Announces The First Shipment Of Its Generic Product In The U.S. Market 3/17/2015 6:52:25 AM
TWi Pharmaceuticals, Inc. Receives Rare Disease Drug Designation For Its Drug Candidate AC-203 In Taiwan 3/10/2015 7:18:27 AM
TWi Pharmaceuticals, Inc. Announces That Its Board Has Appointed Ms. Tina Guilder As The President & CEO And Ms. Eva Ho As CFO To Enhance The Strategic Move To Commercialize Its Products In The U.S. Market. 3/5/2015 7:40:39 AM
TWi Pharmaceuticals, Inc. Announces That It Will Sell Its Products In The U.S. Market, Originally Planned To Be Sold By Teva, Through Its Wholly-Owned Subsidiary, TWi Pharmaceuticals USA 2/24/2015 6:52:20 AM
Supernus Pharmaceuticals (SUPN) Sues TWi Pharmaceuticals, Inc. For Infringement Of Oxtellar XR® Patents 1/22/2015 8:14:41 AM
TWi Pharmaceuticals, Inc. Receives Approval Of Protocol For Its Drug Ac-201 Controlled-Release Tablet, Phase 2 Clinical Trial In Both The United States And Taiwan 12/12/2014 7:24:31 AM
TWi Pharmaceuticals, Inc. Receives U.S. FDA Approval On Generic Donepezil Hydrochloride Tablets USP, 23 Mg, Its Fifth ANDA From U.S. FDA 10/30/2014 7:41:56 AM
12